menu search

EVFM / Evofem Shares Jump On Interim Q4 Sales, Phexxi Prescriptions

Evofem Shares Jump On Interim Q4 Sales, Phexxi Prescriptions
Evofem Biosciences Inc (NASDAQ: EVFM) achieved preliminary net product sales of $3.5 million in Q4 FY21, more than double in Q3 FY21. During the quarter, 39,121 boxes of Phexxi were dispensed, up 81% from Q3. Read More
Posted: Jan 19 2022, 12:48
Author Name: Benzinga
Views: 111260

EVFM News  

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
August 4, 2022

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2022 Results - Earnings Call Transcript

Evofem Biosciences, Inc. (NASDAQ:EVFM ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Amy Raskopf - Vice President-I more_horizontal

A Market Breakout is Coming

By InvestorPlace
July 6, 2022

A Market Breakout is Coming

A huge battle playing out between the bulls and bears … so much rests on Q2 earnings … get ready for a month of important data releases The market more_horizontal

EVFM Stock: Contraception Maker Evofem Biosciences Doubles After Roe Decision

By InvestorPlace
June 27, 2022

EVFM Stock: Contraception Maker Evofem Biosciences Doubles After Roe Decision

Evofem Biosciences is in the spotlight following the overturning of Roe v. Wade. Here's why EVFM stock is a name to watch. more_horizontal

Evofem's stock is still soaring after Friday's Supreme Court decision

By Market Watch
June 27, 2022

Evofem's stock is still soaring after Friday's Supreme Court decision

Shares of Evofem Biosciences Inc. EVFM, +155.45% soared 164.6% in trading on Monday in a rally that began Friday when the Supreme Court decision strik more_horizontal

Evofem's stock jumps 30% after Supreme Court decision on Roe v. Wade

By Market Watch
June 24, 2022

Evofem's stock jumps 30% after Supreme Court decision on Roe v. Wade

Shares of Evofem Biosciences Inc. EVFM, +26.95% soared 30.6% in trading on Friday, hours after the Supreme Court decision striking down Roe v. Wade wa more_horizontal

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 4, 2022

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2022 Results - Earnings Call Transcript

Evofem Biosciences, Inc. (NASDAQ:EVFM ) Q1 2022 Results Conference Call May 4, 2022 4:30 PM ET Company Participants Amy Raskopf - Vice President-Inves more_horizontal

Evofem to Present New Research in Gynecological Health at the 2022 American College of Obstetricians and Gynecologists Annual Meeting

By PRNewsWire
April 26, 2022

Evofem to Present New Research in Gynecological Health at the 2022 American College of Obstetricians and Gynecologists Annual Meeting

SAN DIEGO , April 26, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it will present new data from the Phase 3 AMPO more_horizontal

Evofem Biosciences' (EVFM) CEO Saundra Pelletier on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 3, 2022

Evofem Biosciences' (EVFM) CEO Saundra Pelletier on Q4 2021 Results - Earnings Call Transcript

Evofem Biosciences' (EVFM) CEO Saundra Pelletier on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: